"Cardiomyopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
Descriptor ID |
D009202
|
MeSH Number(s) |
C14.280.238
|
Concept/Terms |
Cardiomyopathies- Cardiomyopathies
- Cardiomyopathy
- Myocardial Diseases
- Disease, Myocardial
- Diseases, Myocardial
- Myocardial Disease
- Myocardiopathies
- Myocardiopathy
Cardiomyopathies, Secondary- Cardiomyopathies, Secondary
- Cardiomyopathy, Secondary
- Secondary Cardiomyopathies
- Secondary Cardiomyopathy
- Secondary Myocardial Diseases
- Disease, Secondary Myocardial
- Diseases, Secondary Myocardial
- Myocardial Disease, Secondary
- Secondary Myocardial Disease
- Myocardial Diseases, Secondary
Cardiomyopathies, Primary- Cardiomyopathies, Primary
- Cardiomyopathy, Primary
- Primary Cardiomyopathies
- Primary Cardiomyopathy
- Primary Myocardial Diseases
- Myocardial Diseases, Primary
- Disease, Primary Myocardial
- Diseases, Primary Myocardial
- Myocardial Disease, Primary
- Primary Myocardial Disease
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathies".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathies".
This graph shows the total number of publications written about "Cardiomyopathies" by people in this website by year, and whether "Cardiomyopathies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1997 | 1 | 2 | 3 |
1998 | 1 | 0 | 1 |
1999 | 1 | 1 | 2 |
2000 | 2 | 0 | 2 |
2001 | 1 | 1 | 2 |
2002 | 0 | 2 | 2 |
2003 | 2 | 0 | 2 |
2004 | 3 | 0 | 3 |
2005 | 2 | 1 | 3 |
2006 | 2 | 1 | 3 |
2007 | 2 | 1 | 3 |
2008 | 3 | 0 | 3 |
2009 | 3 | 1 | 4 |
2010 | 3 | 1 | 4 |
2011 | 4 | 2 | 6 |
2012 | 4 | 3 | 7 |
2013 | 3 | 3 | 6 |
2014 | 10 | 2 | 12 |
2015 | 3 | 3 | 6 |
2016 | 7 | 1 | 8 |
2017 | 11 | 2 | 13 |
2018 | 11 | 1 | 12 |
2019 | 3 | 0 | 3 |
2020 | 9 | 2 | 11 |
2021 | 5 | 0 | 5 |
2022 | 8 | 0 | 8 |
2023 | 10 | 0 | 10 |
2024 | 4 | 4 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiomyopathies" by people in Profiles.
-
Perivascular Amyloid Deposition in Immunoglobulin Light Chain Cardiac Amyloidosis and Its Implications on Echocardiographic Cardiac Remodeling. J Am Soc Echocardiogr. 2024 Oct; 37(10):1010-1012.
-
Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype. Curr Probl Cardiol. 2024 Sep; 49(9):102729.
-
As Good as it Gets: SGLT2 Inhibitors in Cardiac Amyloidosis. J Am Coll Cardiol. 2024 Jun 18; 83(24):2423-2425.
-
Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
-
Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice. Cell Rep. 2024 Jun 25; 43(6):114284.
-
Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias. J Am Heart Assoc. 2024 May 21; 13(10):e030467.
-
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human. Sci Transl Med. 2024 Apr 17; 16(743):eadi0077.
-
Physiological stress improves stem cell modeling of dystrophic cardiomyopathy. Dis Model Mech. 2024 Jun 01; 17(6).
-
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. N Engl J Med. 2023 Oct 26; 389(17):1553-1565.
-
Loss of heme oxygenase 2 causes reduced expression of genes in cardiac muscle development and contractility and leads to cardiomyopathy in mice. PLoS One. 2023; 18(10):e0292990.